Literature DB >> 10646125

Expression of FGFR3 with the G380R achondroplasia mutation inhibits proliferation and maturation of CFK2 chondrocytic cells.

J E Henderson1, M C Naski, M M Aarts, D Wang, L Cheng, D Goltzman, D M Ornitz.   

Abstract

A G380R substitution in the transmembrane-spanning region of FGFR3 (FGFR3Ach) results in constitutive receptor kinase activity and is the most common cause of achondroplastic dwarfism in humans. The epiphyseal growth plates of affected individuals are disorganized and hypocellular and show aberrant chondrocyte maturation. To examine the molecular basis of these abnormalities, we used a chondrocytic cell line, CFK2, to stably express the b variant of wild-type FGFR3 or the the constitutively active FGFR3Ach. Overexpression of FGFR3 had minimal effects on CFK2 proliferation and maturation compared with the severe growth retardation found in cells expressing FGFR3Ach. Cells expressing the mutant receptor also showed an abnormal apoptotic response to serum deprivation and failed to undergo differentiation under appropriate culture conditions. These changes were associated with altered expression of integrin subunits, which effectively led to a switch in substrate preference of the immature cell from fibronectin to type II collagen. These in vitro observations support those from in vivo studies indicating that FGFR3 mediates an inhibitory influence on chondrocyte proliferation. We now suggest that the mechanism is related to altered integrin expression.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10646125     DOI: 10.1359/jbmr.2000.15.1.155

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  13 in total

Review 1.  Sixteen years and counting: the current understanding of fibroblast growth factor receptor 3 (FGFR3) signaling in skeletal dysplasias.

Authors:  Silvie Foldynova-Trantirkova; William R Wilcox; Pavel Krejci
Journal:  Hum Mutat       Date:  2011-11-16       Impact factor: 4.878

Review 2.  FGF signaling in the developing endochondral skeleton.

Authors:  David M Ornitz
Journal:  Cytokine Growth Factor Rev       Date:  2005-04-01       Impact factor: 7.638

Review 3.  Coordination of chondrogenesis and osteogenesis by hypertrophic chondrocytes in endochondral bone development.

Authors:  Hironori Hojo; Shinsuke Ohba; Fumiko Yano; Ung-il Chung
Journal:  J Bone Miner Metab       Date:  2010-07-06       Impact factor: 2.626

4.  Coordination of chondrogenesis and osteogenesis by fibroblast growth factor 18.

Authors:  Zhonghao Liu; Jingsong Xu; Jennifer S Colvin; David M Ornitz
Journal:  Genes Dev       Date:  2002-04-01       Impact factor: 11.361

Review 5.  Tissue engineered bone mimetics to study bone disorders ex vivo: Role of bioinspired materials.

Authors:  Yuru Vernon Shih; Shyni Varghese
Journal:  Biomaterials       Date:  2018-06-06       Impact factor: 12.479

6.  A gain-of-function mutation of Fgfr2c demonstrates the roles of this receptor variant in osteogenesis.

Authors:  Veraragavan P Eswarakumar; Mark C Horowitz; Rachel Locklin; Gillian M Morriss-Kay; Peter Lonai
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-17       Impact factor: 11.205

Review 7.  Modeling craniofacial and skeletal congenital birth defects to advance therapies.

Authors:  Cynthia L Neben; Ryan R Roberts; Katrina M Dipple; Amy E Merrill; Ophir D Klein
Journal:  Hum Mol Genet       Date:  2016-06-26       Impact factor: 6.150

8.  Parathyroid hormone receptor type 1/Indian hedgehog expression is preserved in the growth plate of human fetuses affected with fibroblast growth factor receptor type 3 activating mutations.

Authors:  Sarah Cormier; Anne-Lise Delezoide; Catherine Benoist-Lasselin; Laurence Legeai-Mallet; Jacky Bonaventure; Caroline Silve
Journal:  Am J Pathol       Date:  2002-10       Impact factor: 4.307

9.  A positive FGFR3/FOXN1 feedback loop underlies benign skin keratosis versus squamous cell carcinoma formation in humans.

Authors:  Anna Mandinova; Vihren Kolev; Victor Neel; Bing Hu; Wesley Stonely; Jocelyn Lieb; Xunwei Wu; Claudia Colli; Rong Han; Michael J Pazin; Mike Pazin; Paola Ostano; Reinhard Dummer; Janice L Brissette; G Paolo Dotto
Journal:  J Clin Invest       Date:  2009-10       Impact factor: 14.808

Review 10.  Signaling Pathways in Bone Development and Their Related Skeletal Dysplasia.

Authors:  Alessandra Guasto; Valérie Cormier-Daire
Journal:  Int J Mol Sci       Date:  2021-04-21       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.